OncoCyte Corporation

Q2 2026 13F Holders

Symbol
IMDX
CUSIP
68235C206
Type
Equity
Class
COM NEW
Num filings
40
Total reported value, excl. options
$109 M
Manager Report Date Value ($000) Shares Option Type